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Background: The use of psychoactive substances to neuroenhance cognitive performance is prevalent.
Neuroenhancement (NE) in everyday life and doping in sport might rest on similar attitudinal representations, and
both behaviors can be theoretically modeled by comparable means-to-end relations (substance-performance). A
behavioral (not substance-based) definition of NE is proposed, with assumed functionality as its core component. It
is empirically tested whether different NE variants (lifestyle drug, prescription drug, and illicit substance) can be
regressed to school stressors.
Findings: Participants were 519 students (25.8 ± 8.4 years old, 73.1% female). Logistic regressions indicate that a
modified doping attitude scale can predict all three NE variants. Multiple NE substance abuse was frequent.
Overwhelming demands in school were associated with lifestyle and prescription drug NE.
Conclusions: Researchers should be sensitive for probable structural similarities between enhancement in everyday
life and sport and systematically explore where findings from one domain can be adapted for the other. Policy
makers should be aware that students might misperceive NE as an acceptable means of coping with stress in
school, and help to form societal sensitivity for the topic of NE among our younger ones in general.
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A researcher who chooses to pull an “all-nighter” to meet a
submission deadline might be tempted to use Ritalin to
prolong concentration and vigilance. This use of psycho-
active substances to enhance one’s cognitive functioning,
without the medical indication to do so, is prevalent [1-4].
For this behavior the term neuroenhancement (NE) has
been coined [5]. NE is subject to ongoing debates in
epidemiology and neuroethics. Issues of fairness and health
have been emphasized in the light of a supposedly rising
prevalence of NE among students [6]. It is important not to
add to an untimely and unrealistic “media hype” at this
stage of research however [7]. Most of the social science
research published to date is aimed at describing NE preva-
lence and tends to neglect to ask why it might be prevalent.
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distribution, and reproduction in any mediumat least questionable. Especially empirical studies on NE’s
possible psychological roots are very scarce at the time.
This picture, including the extant problems with defining
the phenomenon more consistently [8], is similar to what
could be observed during the emerging years of social sci-
ence research on doping in sport. Thus, one of the central
claims of this article is that a projection of research
strategies, fundamental assumptions, and underlying theor-
ies from the sporting domain may help to understand the
psychology of NE.
Doping in sport is known to be associated with severe
health consequences and in most competitive sports, it
is seized with rigorous legal sanctions [9]. Both, health
consequences and legal restrictions are also discussed
with respect to NE [10,11]. Researchers have referred to
a shared subjective “morality” of using performance enhan-
cing substances in sport and everyday life [12]. With regard
to drug abuse in everyday life, drug instrumentalization
theory [13] postulates that non-addictive drug use can be
explained by the individual’s expectation, that substancestral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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[14,15]. Similar arguments have been introduced to the
doping literature [16]. With regard to both domains, taking
goal system theory [17] as an exemplary theoretical
framework, the use of a performance enhancing sub-
stance represents a functional means to achieve a highly
valued end. In the sporting domain, erythropoietin
(EPO) is employed for improving one’s athletic endurance,
making winning more probable. In the NE domain,
methylphenidate (e.g., in Ritalin) can be used as a means to
prolong concentration during learning sessions [13], thus
facilitating the end of academic success. It is a worthwhile
hypothesis that basic psychological representations of these
two behaviors are therefore similar.
Attitudes are defined as the individual’s subjective
evaluation of a person or object, and represent such a
basic psychological representation [18]. Attitudes have
been shown to be amongst the strongest predictors for
doping [19], and doping specific attitude scales have
been shown to predict doping intentions and behavior
[20]. Attitudes are a promising target construct for NE
researchers not only because they can predict behavior;
but also because they might form before this behavior
occurs. It is true that attitudes may also result from
previous behavioral choices [21]. However, to prevent a
behavior from occurring, changing peoples’ attitudes has
been shown to be one of the superordinate goals of
preventative interventions in the doping domain [22]. Our
proposition is to measure NE attitudes with an adapted
version (domain specific enhancement scale) of an inter-
nationally validated doping attitude scale therefore.
Another parallel between NE and doping in sport might
be seen in the use of performance enhancing substances
in order to cope with stress and anxiety. With regard to
doping in sport, authors have proposed that athletes are
more likely to use illicit substances if demands are high
and they appraise their own resources as insufficient to
cope with these demands [16]. Alcohol is one substance,
which is employed by students to reduce experienced
pressure to perform [23]. More recent exploratory studies
have also found correlations between global psychological
distress in college students and NE [24]. One study even
concludes that “some students take drugs to manage
the current vast study demands ([2]; p. 268)”. This study
did not include measures to explicitly assess these demands
however. It is a worthwhile hypothesis that diverse NE
substances may be employed as coping means.
With respect to which substances might be regarded as
being suitable as coping means, we argue for a behavioral
definition of NE. From this viewpoint, NE aims at the
enhancement or rebuilding of cognitive performance
(means-to-end relation), thus representing one of the
nine instrumentalization goals [13,15] attributed to system-
atic non-addictive drug use (the others are: improved socialinteraction, facilitated sexual behavior, facilitated recovery
from and coping with psychological stress, euphoria and
hedonia, improved physical appearance and attractiveness,
self-medication for mental problems, sensory curiosity and
facilitating spiritual and religious activities). This behavioral
viewpoint neither implies that the substance is a prescrip-
tion drug or not (for problems with the substance-based
definition of doping in sport see [25]), nor that it is effective
(for the often overestimated expectations regarding typical
NE substances see [26]), nor that it could not be used
for resolving other annoying states (e.g., indulgence or
boredom). Our behavioral viewpoint thus includes the
first claim made by drug instrumentalization theory
(substances are used as instruments) but does not ne-
cessarily imply the second one (substances increase
performance through changes in mental states). The
assumed functionality of the behavior is its key defin-
itional aspect: If a person consumes a substance with
the goal to improve cognitive performance, and if he or
she assumes (subjectively expects) that this substance is
able to improve his or her cognitive performance, this
person is neuroenhancing. For example, caffeinated drinks
(“energy drinks”) are consumed frequently among younger
people [27,28]. If such drinks are explicitly consumed to
enhance cognitive performance they are means to an end;
and therefore qualify as neuroenhancers. Epidemiological
evidence on the use of such lifestyle neuroenhancers is
widely lacking (for one exception see [29]).
While we focus on the assumed functionality of NE,
it has to be noted that the actual effects of enhancing
substances vary greatly between individuals [30]. Enhancers
have shown to be more effective in novel situations
[31] and for participants with poor memory capacity
[32] for example.
With regard to substances we propose three NE variants:
lifestyle drug NE (e.g., high dosed caffeinated drinks),
prescription drug NE (e.g., Methylphenidate) and illicit
substance NE (e.g., Cocaine). For lifestyle drug NE,
substances like coffee or caffeinated drinks, lifetime
prevalence in students has been reported to be 53.2% and
39% respectively [29]. Lifetime prevalence of prescription
drug and illicit substance NE among US American students
(University and College) have been found to range between
7 and 9% [6,33,34]. One recent study, which has employed
a randomized response technique in order to better
account for social sensitivity of the issue, suggests the
one-year prevalence for prescription and illicit drug
NE among German students to be as high as 20% [4].
The advantage of distinguishing between these three
NE variants is (at least) twofold. Firstly it allows for a
much more faceted view of the phenomenon, and its
behavioral basis respectively. Secondly, it allows for
describing multiple NE substance abuse. This is relevant, as
lifestyle drug NE may pave the road for later prescription
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way hypothesis in the doping in sport literature, [35]). A
few studies in the doping domain have already investigated
the (mental) relation of doping and recreational drugs
[36-38] or nutritional supplements [38]. The extant litera-
ture on NE has not drawn on this possible link as yet.
Based on these assumptions our empirical hypotheses
are as follows:
Hypothesis 1 (multiple NE substance abuse): Use of
lifestyle drug NE is associated with a higher probability
of prescription drug and illicit substance NE.
Hypothesis 2 (domain specific enhancement attitude):
Self-reported use of lifestyle, prescription drug and illicit
substance NE can be predicted by a domain specific
(i.e., NE) variant of a doping attitude scale.
Hypothesis 3 (NE and stress in school): Pressure to
perform, test anxiety and overwhelming demands can be
used to incrementally (over and above the effects of age
and gender; see below) predict the three NE variants.
Methods
Setting, sample and procedure
The study was conducted in a vocational school in
Germany (students must be graduated from secondary
school, therefore having at least ten years of prior educa-
tion, if they choose to enroll in a vocational school) Partici-
pants were 519 students (73.1% female), representing a
self-selected sample (61.1%) from this school’s 850 students.
Mean sample age was 25.8 ± 8.4 years. Participants filled
out a paper and pencil questionnaire anonymously during
class. All participants gave full informed consent prior
to the measurement. Ethical approval for the study was
granted by the University of Potsdam.
Measures
Participants were asked whether or not they have ever
used an NE substance (“Have you ever used a substance
with the goal to increase your cognitive performance”)
on separate questionnaire pages for lifestyle, prescription
drug and illicit substance NE. Emphasis was laid on the
functional aspect of consumption so that participants
would not report for example their morning cup of coffee.
The most prevalent substances for lifestyle NE (e.g., func-
tional use of coffee, caffeine pills, creatine, energy drinks)
and prescription drug NE (e.g., methylphenidate, modafinil,
beta-blocker) were listed as examples. Because of social
sensitivity issues, no list was provided for illicit substance
NE. Above that, participants had to indicate their fre-
quencies of use, separately for lifestyle and prescription
NE (not for illicit substance NE) on a 6-point Likert-type
scale from 0 = “never” to 5 = “several times a day”.
Pressure to perform was assessed using the revised [39]
5-item version of the Pressure-to-Perform-Scale [40]. Test
anxiety was assessed using the [39] 5-item version of theTest Anxiety Inventory [41]. Both instruments showed
sufficient psychometric properties in previous studies. In
our sample these scales reached internal consistencies
(Cronbach’s -α) of .76 and .87 respectively. Overwhelming
demands in school was assessed with the single question
“Are you overwhelmed by the demands in school”. Answers
had to be given on a 5-point Likert-type scale (ranging from
1, “I don’t feel overwhelmed” to 5, “I do feel overwhelmed”).
NE attitude was assessed using a modified 9-item version
(items 1, 2, 4, 6, 7, 11, 13, 15 and 16) of the Performance
Enhancement Attitude Scale [20]. These items were
adapted by replacing doping related terminology with
that of neuroenhancement, and the context of sport
performance to that of academic performance. This
adapted scale will be labeled NEAS throughout this
manuscript. Its internal consistency was α = .79 in our
sample. Factorial structure of the NEAS is provided as
supplemental material [Additional file 1].
Statistical analyses
The hypothesis on multiple NE substance abuse (H1)
was tested with a χ2-test. To test the domain specific NE
attitude (H2) and the NE and stress in school (H3) hypoth-
eses, six stepwise multiple logistic regression analyses were
conducted, with either lifestyle, prescription drug or illicit
substance NE as dependent variables. For testing H2 and
H3 we conducted two stepwise multiple linear regression
analyses with lifestyle NE frequency being the dependent
variable. Step one is to control for the variables sex and age
(as these two variables are known to make a difference in
NE behavior; [4]). In step two either the NE attitude (to test
the domain specific enhancement attitude hypothesis; H2),
or test anxiety, pressure to perform and excessive demands
is included (NE and stress in school hypothesis; H3).
Results
Descriptive statistics as well as detailed results of all linear
regression analyses are depicted in Tables 1 and 2.
Multiple NE substance abuse
For prescription drug and illicit substance NE both χ2-tests
were significant, χ2(1) = 12.08, p < .01, and χ2(1) = 17.96, p
< .01 respectively. Odds ratios illustrate that users of life-
style drug NE had a higher chance of prescription drug
(OR = 4.72, CI95 = 1.82 - 12.24) and illicit substance use,
OR = 8.75, CI95 = 2.66 - 28.73. These results support the
multiple NE substance abuse hypothesis.
Domain specific enhancement attitude
The omnibus tests of model coefficients for step-one of the
logistic regression models were significant for lifestyle drug
(χ2(2) = 14.74, p < .01) and illicit substance NE, χ2(2) =
18.35, p < .01. The test for prescription drug NE was not
significant, χ2(2) = 1.69, p = .43. Age significantly predicted
Table 1 Descriptive statistics
M SD
NEAS 2.80 0.86
Pressure to Perform 2.91 0.77
Test Anxiety 2.65 1.01
Overwhelming
Demands
2.36 0.96
Prevalence
Yes No
Prescription-drug NE 8.00% 92.00%
Illicit-substance NE 8.80% 91.20%
Lifestyle-drug NE 62.60% 37.40%
Lifestyle-drug NE: monthly weekly twice
a week
daily several times
a day
Frequency of usea
14.90% 10.90% 9.70% 19.20% 45.30%
a Percentage only from those who have admitted lifestyle-drug NE.
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males were more likely to use illicit substances, OR = 3.98,
p < .01, CI95 = 2.01 - 7.77. No significant results were found
for the remaining associations of age and gender with the
other NE variants (all p’s ≥ .11) and the frequency of lifestyle
drug NE, all p’s ≥ .16. Because of a lack in statistical power
(due to the few “yes”-responses obtained) frequency of use
data for prescription drug NE could not be analyzed with
linear regression analysis.
The omnibus tests of model coefficients for step-two
of the logistic regression models were significant for
lifestyle drug (χ2(1) = 35.68, p < .01), prescription drug
(χ2(1) = 22.71, p < .01) and illicit substance NE, χ2(1) = 28.89,
p < .01. NEAS explained incremental variance (over andTable 2 Results of linear regression analyses predicting
frequency of lifestyle NE use
Enhancement attitude (H2) Stress in school (H3)
Predictora ΔR2 β df Predictora ΔR2 β df
Step 1 .006 2, 428 Step 1 .005 2, 432
Sex -.07 427 Sex -.06 431
Age .05 427 Age .04 431
Step 2 .027** 1, 427 Step 2 .034** 3, 429
NEAS .17** 426 Pressure
to Perform
-.11 428
Test Anxiety .02 428
Overwhelming
Demands
.22** 428
Total R2 .034** 3, 427 .039** 5, 429
Total F 18.03** 12.48**
nb 430 434
a Test statistic for significance testing of all R2’s and ΔR2’s is the F-statistic, test
statistic for significance testing of all β’s is the t-statistic.
b Differences in n and test scores for step one are due to missing values in the
respective analyses. ** p < .01.above the effects of age and gender) in the probability of
lifestyle drug (OR = 2.11, p < .01, CI95 = 1.62 - 2.74), pre-
scription drug (OR = 2.67, p < .01, CI95 = 1.76 - 4.03) and
illicit substance NE, OR = 2.98, p < .01, CI95 = 1.96 - 4.55.
Above that, NEAS scores were significant predictors for
the frequency of lifestyle drug NE. This data support the
hypothesis, that frequency of NE can be predicted by
NE attitude, as measured by the domain specific (NE)
enhancement attitude scale NEAS.
NE and stress in school
Regression models for lifestyle drug, and illicit substance
NE remained both insignificant, χ2(3) = 4.09, p = .25, and
χ2(3) = 2.78, p = .43. Yet the omnibus test for prescription
drug NE was significant, χ2(3) = 14.98, p < .01. Overwhelm-
ing demands was the only predictor to explain incremental
variance (over and above the effects of age and gender) in
this model, OR = 2.30, p < .01, CI95 = 1.39 - 3.79. The same
variable, overwhelming demands was the only significant
predictor for frequency of lifestyle drug NE (Table 2). This
data provides partial support for our hypothesis on NE and
stress in school.
Discussion
This study found support for the hypotheses that lifestyle
drug NE is associated with prescription drug, as well as
illicit substance NE (multiple substance abuse). Further,
the hypothesis that NE can be predicted by an adapted
doping attitude test (NEAS) was supported. Prescription
drug and the frequency of lifestyle substance NE could be
predicted by overwhelming demands in school.
We did not aim at measuring prevalence rates (this would
not have been reasonable with a self-selected sample).
Yet it speaks in favor of the validity and generalizability
of the reported results, that in our sample the observed
frequencies of use of prescription drugs and illicit sub-
stances were similar to the ones reported in previously
published studies [6,29,33,35].
Compared to non-users, lifestyle drug NE users were
more likely to be prescription drug and illicit substance
users. This pattern of multiple NE abuse mirrors the
phenomenon of polydrug use in substance addiction.
Polydrug use is prevalent and has a strong impact on pub-
lic health [42]. Research findings as well as preventative or
rehabilitative strategies of dealing with this phenomenon
can possibly be adapted to the NE domain.
Neither pressure to perform nor test-anxiety was cor-
related with any of the three NE variants. However,
overwhelming demands explained incremental variance
in prescription, as well as in frequency of lifestyle drug
NE. This finding supports the stress theoretical claim
that a situation has to be appraised as overwhelming to
cause stress and maladaptive coping strategies. Preventative
accounts should therefore focus on individuals, who
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their coping resources.
Further, the other stressors’ lack of incremental validity
leads us to propose the hypothesis that NE might at least
partly reflect some kind of a lifestyle aspect. This would
call for an even broader construct of enhancement. It is
impossible to rule out that further conceptual issues
(e.g., specific drugs asked for; method artifacts) could have
accounted for the absence of these results. We think
that future studies should investigate also the possibility
of stress-independent enhancement and psychological
variables associated with it.
We have argued that NE and doping in sports draw
back on similar psychological representations about
enhancement behavior. As expected, the adapted (NE
domain specific) doping attitude scale (NEAS) was able
to predict NE. Exponential beta coefficients (odds ratios)
of NEAS were lowest for lifestyle drug and highest for illicit
substance NE. This ordinal rank is comparable to the legal
supplement to illegal doping rank order in sport. Building
on this interpretation we suggest that enhancement
(everyday life as well as doping in sport) can be conceptual-
ized along the two orthogonal dimensions health and sanc-
tions. This conceptualization could predict closer proximity
of illicit NE and doping (severe sanctions and severe
health consequences) compared to prescription drug NE
(sanctions and health consequences moderate to severe)
and lifestyle drug NE (no sanctions and low to moderate
health consequences), and thus explain higher incremental
validity of NEAS scores in this domain. This orthogonal
conceptualization has the advantage of taking the di-
mensions’ relative independence into account (e.g., legality
depends on jurisdiction, and health consequences depend
on the individual’s substance specific lay knowledge). Future
studies should test this hypothesis, and maybe include add-
itional dimensions such as lifestyle (see above) or function-
ality to draw an even closer description of the behavior.
Limitations
Although all students of the selected vocational school
were asked to fill out the questionnaire, 32% did not
participate. Not knowing who chose not to participate,
selective attrition cannot be ruled out. Hence we again
emphasize that our study does not represent an epidemio-
logical account on NE prevalence. Still, given the above
reported, comparable NE prevalence rates from other stud-
ies, we propose that our sample sufficed for investigating
the proposed research question: The relationship of psycho-
logical constructs and NE behavior.
Unfortunately, we did not assess the use and patterns
of one distinct and widely used drug, which is often con-
sumed to better cope with psychological demands: Alcohol
[43]. It is possible that students, who use alcohol to cope
with stress, might be less likely to utilize other substances,for example illicit drugs. We further did not assess
addiction-like use patterns. Addiction-like use could
deflate the predictor-NE associations we have found.
This possible moderating and deflating effects should
be addressed in future studies.
Implications
The present study advances the field of NE research by fo-
cusing on NE behavior. With regard to their psychological
bases, neuroenhancement in everyday life and doping in
sport may be comparable phenomena. Even after our study,
in which we have drawn conceptual parallels, researchers
should directly (empirically) investigate into these similar-
ities. To arrive at causal explanations then, for example on
possible gateways from NE in everyday life to doping in
sport (or the other way round), prospective studies and
experimental designs are urgently needed.
Policy makers might want to address school environment
factors since overwhelming demands seem to be related
to NE behavior. Even more, they should be aware that
students might misperceive NE as an acceptable means
of coping with stress in school, and help to form societal
sensitivity for the topic of NE among our younger ones
in general.
Additional file
Additional file 1: Factorial structure of the Neuroenhancement
Attitude Scale (NEAS).
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
WW and RB designed the study. WW conducted the statistical calculations
and wrote the first draft of the manuscript. RB revised the first draft and
conducted the statistical analyses for the supplemental material. Both
authors then jointly worked on all subsequent versions of the manuscript.
Both authors read and approved the final manuscript.
Acknowledgements
We would like to thank Mr. Benjamin Ebeling for his contribution to data
collection and Ms Svenja Pallowski for her assistance in editing this
manuscript.
Received: 20 February 2013 Accepted: 9 June 2013
Published: 18 June 2013
References
1. Franke AG, Hildt E, Lieb K: Patterns of misuse of stimulants for
pharmacological neuroenhancement in students. Suchttherapie 2011,
12(4):167–172.
2. Mache S, Eickenhorst P, Vitzthum K, Klapp BF, Groneberg DA:
Cognitive-enhancing substance use at German universities: frequency,
reasons and gender differences. Wien Med Wochenschr 2012, 162:11–12.
3. Maher B: Poll results: look who's doping. Nature 2008, 452(7188):674–675.
4. Dietz P, Striegel H, Franke AG, Lieb K, Simon P, Ulrich R: Randomized
response estimates for the 12-month prevalence of cognitive-enhancing
drug use in university students. Pharmacotherapy 2013, 33(1):44–50.
5. Hall W: Feeling 'better than well' - Can our experiences with
psychoactive drugs help us to meet the challenges of novel
neuroenhancement methods? EMBO Rep 2004, 5(12):1105–1109.
Wolff and Brand Substance Abuse Treatment, Prevention, and Policy 2013, 8:23 Page 6 of 6
http://www.substanceabusepolicy.com/content/8/1/236. Teter CJ, McCabe SE, Cranford JA, Boyd CJ, Guthrie SK: Prevalence and
motives for illicit use of prescription stimulants in an undergraduate
student sample. J Am Coll Health 2005, 53(6):1501–1510.
7. Partridge BJ, Bell SK, Lucke JC, Yeates S, Hall WD: Smart drugs "as common
as coffee": media hype about neuroenhancement. PLoS One 2011,
6(11):96–106.
8. Smith ME, Farah MJ: Are prescription stimulants “smart pills”? The
epidemiology and cognitive neuroscience of prescription stimulant use
by normal healthy individuals. Psychol Bull 2011, 137(5):717–741.
9. Strelan P, Boeckmann RJ: Why drug testing in elite sport does not work:
perceptual deterrence theory and the role of personal moral beliefs.
J Appl Soc Psychol 2006, 36(12):2909–2934.
10. Forlini C, Racine E: Considering the causes and implications of ambivalence
in using medicine for enhancement. Am J Bioeth 2011, 11(1):15–17.
11. Outram SM: The use of methylphenidate among students: the future of
enhancement? J Med Ethics 2010, 36(4):198–202.
12. Dodge T, Williams KJ, Marzell M, Turrisi R: Judging cheaters: is substance
misuse viewed similarly in the athletic and academic domains? Psychol
Addict Behav 2012, 26(3):678–682.
13. Mueller CP, Schumann G: Drugs as instruments: a new framework for
non-addictive psychoactive drug use. Behav Brain Sci 2011, 34(6):293–310.
14. Pickard H: The instrumental rationality of addiction. Behav Brain Sci 2011,
34(6):320–321.
15. Mueller CP, Schumann G: To use or not to use: expanding the view on
non-addictive psychoactive drug consumption and its implications.
Behav Brain Sci 2011, 34(6):328–347.
16. Petróczi A, Aidman E: Psychological drivers in doping: the life-cycle model
of performance enhancement. Subst Abuse Treat Prev Policy 2008, 3:7.
17. Kruglanski AW, Shah JY, Fishbach A, Friedman R, Chun WY, Sleeth-Keppler
D: A theory of goal systems. In Advances in Experimental Social Psychology.
Volume 24. Edited by Zanna MP. San Diego: Academic Press; 2002:331–378.
18. Olson JM, Zanna MP: Attitudes and attitude-change. Annu Rev Psychol
1993, 44:117–154.
19. Wiefferink CH, Detmar SB, Coumans B, Vogels T, Paulussen TGW: Social
psychological determinants of the use of performance-enhancing drugs
by gym users. Health Educ Res 2008, 23(1):70–80.
20. Petróczi A, Aidman E: Measuring explicit attitude toward doping: review
of the psychometric properties of the performance enhancement
attitude scale. Psychol Sport Exerc 2009, 10(3):390–396.
21. Festinger L, Carlsmith JM: Cognitive consequences of forced compliance.
J Abnorm Soc Psychol 1959, 58(2):203–210.
22. Lentillon-Kaestner V, Hagger MS, Hardcastle S: Health and doping in
elite-level cycling. Scand J Med Sci Sports 2012, 22(5):596–606.
23. Kieffer KM, Cronin C, Gawet DL: Test and study worry and emotionality in
the prediction of college students' reasons for drinking: an exploratory
investigation. J Alcohol Drug Educ 2006, 50(1):57–81.
24. Weyandt LL, Janusis G, Wilson KG, Verdi G, Paquin G, Lopes J, Dussault C:
Nonmedical prescription stimulant use among a sample of college
students relationship with psychological variables. J Atten Disord 2009,
13(3):284–296.
25. Lippi G, Franchini M, Guidi GC: Doping in competition or doping in sport?
Br Med Bull 2008, 86(1):95–107.
26. Repantis D, Schlattman P, Laisney O, Heuser I: Modafinil and
methylphenidate for neuroenhancement in healthy individuals: a
systematic review. Pharmacol Res 2010, 62(3):187–206.
27. Malinauskas BM, Aeby VG, Overton RF, Carpenter-Aeby T, Barber-Heidal K:
A survey of energy drink consumption patterns among college students.
Nutr J 2007, 6:35.
28. Normann C, Berger M: Neuroenhancement: status quo and perspectives.
Eur Arch Psychiatry Clin Neurosci 2008, 258(5):110–114.
29. Franke AG, Christmann M, Bonertz C, Fellgiebel A, Huss M, Lieb K: Use of
coffee, caffeinated drinks and caffeine tablets for cognitive enhancement
in pupils and students in germany. Pharmacopsychiatry 2011, 44(7):331–338.
30. Turner DC, Sahakian BJ: The cognition-enhanced classroom. In Reshaping
the Human Condition. Edited by Zonneveld L, Dijstelbloem H, Ringoir D. The
Hague: Ratehau Institute; 2008:107–114.
31. Elliot R, Sahakian BJ, Matthews K, Bannerjea A, Rimmer J, Robbins TW:
Effects of methylphenidate on spatial working memory and planning in
healthy young adults. Psychopharmacology 1997, 131(2):196–206.
32. Mehta MA, Owen AM, Sahakian BJ, Mavadatt N, Pickard JD, Robbins TW:
Methylphenidate enhances working memory by modulating discretefrontal and parietal lobe regions in the human brain. J Neurosci 2000,
20(6):RC65.
33. Lord S, Downs G, Furtaw P, Chaudhuri A, Silverstein A, Gammaitoni A,
Budman S: Nonmedical use of prescription opioids and stimulants
among student pharmacists. J Am Pharm Assoc 2009, 49(4):519–528.
34. McCabe SE, Teter CJ, Boyd CJ: Medical use, illicit use, and diversion of
abusable prescription drugs. J Am Coll Health 2006, 54(5):269–278.
35. Dunn M, Mazanov J, Sitharthan G: Predicting future anabolic-androgenic
steroid use intentions with current substance use: findings from an
internet-based survey. Clin J Sport Med 2009, 19(3):222–227.
36. Uvacsek M, Nepusz T, Naughton DP, Mazanov J, Ránky MZ, Petróczi A:
Self‐admitted behavior and perceived use of performance‐enhancing vs
psychoactive drugs among competitive athletes. Scand J Med Sci Sports
2011, 21(2):224–234.
37. Dunn M, Thomas JO, Swift W, Burns L: Elite athletes' estimates of the
prevalence of illicit drug use: evidence for the false consensus effect.
Drug Alcohol Rev 2012, 31(1):27–32.
38. Petróczi A, Mazanov J, Naughton DP: Inside athletes' minds: preliminary
results from a pilot study on mental representation of doping and potential
implications for anti-doping. Subst Abuse Treat Prev Policy 2011, 6:10.
39. Schwarzer R, Jerusalem ME: Skalen zur Erfassung von Lehrer- und
Schülermerkmalen [Scales for the assessment of teacher and student
characteristics]. Berlin: Freie Universität Berlin; 1999.
40. von Saldern M, Littig KE: Die Konstruktion der Landauer Skalen zum
Sozialklima. Zeitschrift für Entwicklungspsychologie und Pädagogische
Psychologie 1985, 17(2):138–149.
41. Hodapp V, Laux L, Spielberger CD: TAI/D – Test Anxiety Inventory – Deutsche
Fassung [Prüfungsängstlichkeitsinventar; TAI-G]. Zeitschrift für Differentielle und
Diagnostische Psychologie 1982, 3(3):169–184.
42. Kedia S, Sell MA, Relyea G: Mono- versus polydrug abuse patterns among
publicly funded clients. Subst Abuse Treat Prev Policy 2007, 2:33.
43. Williams A, Clark D: Alcohol consumption in university students: the role
of reasons for drinking, coping strategies, expectancies, and personality
traits. Addict Behav 1998, 23(3):371–378.
doi:10.1186/1747-597X-8-23
Cite this article as: Wolff and Brand: Subjective stressors in school and
their relation to neuroenhancement: a behavioral perspective on
students’ everyday life “doping”. Substance Abuse Treatment, Prevention,
and Policy 2013 8:23.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
